Detail akcie Prestige Br Hldg online

Business Summary: Prestige Consumer Healthcare Inc. is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club and e-commerce stores in North America (the United States and Canada) and in Australia and certain other international markets. The Company operates through two segments: North American OTC Healthcare and International OTC Healthcare. Its diverse portfolio of brands include Monistat and Summer’s Eve women's health products, BC and Goody's pain relievers, Clear Eyes and TheraTears eye care products, DenTek specialty oral care products, Dramamine motion sickness treatments, Fleet enemas and glycerin suppositories, Chloraseptic and Luden's sore throat treatments and drops, Compound W wart treatments, Little Remedies pediatric over-the-counter products, Boudreaux’s Butt Paste diaper rash ointments, Nix lice treatment, Debrox earwax remover, and others.
Financial Summary: BRIEF: For the nine months ended 31 December 2023, Prestige Consumer Healthcare Inc revenues increased 1% to $848.4M. Net income increased 1% to $159.9M. Revenues reflect North American OTC Healthcare-Eye & Ear Care segment increase of 8% to $117.7M, North American OTC Healthcare-Dermatologicals segment increase of 5% to $94.3M, International OTC Healthcare-Women's Health segment increase of 25% to $17.2M.